McFarlane et al. reported that the impaired activity of NK cells in CLL is associated with a striking reduction in the frequency and viability of NK cells expressing KIR2DL1 and/or KIR3DL1, which progressively lose their functions over disease course [163]. The gene discussed is KIR2DL1; the disease is B-cell chronic lymphocytic leukemia.